Find Academic Supervisors

• Cancer Metabolism
• Metabolomics
• Drug Resistance
• +4 more

Dr. Esther Zaal serves as an Assistant Professor at Utrecht University's Faculty of Veterinary Medicine, Department of Biomolecular Health Sciences, specializing in Cell Biology, Metabolism & Cancer. Her research focuses on the intersection of cellular metabolism and disease mechanisms, particularly in cancer and immunological contexts. Her research interests center on cancer metabolism, with particular emphasis on metabolic reprogramming in malignancies such as multiple myeloma. Dr. Zaal investigates how metabolic pathways influence drug resistance mechanisms and tumor progression. Her work spans immunometabolism, examining how metabolic processes regulate immune cell function, particularly T cells and dendritic cells. She also explores metabolic vulnerabilities in cancer that could serve as therapeutic targets, with significant work on nucleotide synthesis, amino acid metabolism, and lipid metabolism in tumor cells. Analysis of Dr. Zaal's recent publications reveals a consistent focus on metabolic adaptations in disease states. Her work demonstrates how metabolic rewiring occurs in cancer cells to resist therapeutic interventions and how similar processes affect immune cell function in inflammatory conditions. The research shows particular strength in metabolomics approaches and stable isotope tracing techniques to map metabolic fluxes in various disease models. Dr. Zaal actively supervises research projects and collaborates extensively with the Berkers laboratory and other research groups at Utrecht University. Her work bridges basic metabolic research with potential clinical applications, particularly in developing strategies to overcome drug resistance in cancer treatment. She maintains laboratory facilities focused on metabolomics and cell biology research, utilizing patient-derived organoids, cell culture models, and advanced mass spectrometry techniques to investigate metabolic pathways in health and disease.

• Rheumatology
• Immunology
• Autoimmune Diseases
• +2 more

Dr. Lingli Dong serves as Director, Professor, and Chief Physician in the Department of Rheumatology and Immunology at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology in Wuhan, China, where she also supervises PhD candidates. Her leadership spans clinical care, academic instruction, and research direction within this major medical institution. Her research program centers on autoimmune pathologies including rheumatoid arthritis, psoriasis, Sjögren's syndrome, and IgG4-related disease, with particular emphasis on pandemic response mechanisms and molecular disease pathways. Through clinical investigations and multi-omics approaches, she examines viral interactions with autoimmune conditions, cellular immunology in connective tissue disorders, and therapeutic safety profiles—translating laboratory findings into improved patient management strategies for complex rheumatic diseases. Analysis of Dr. Dong's 2020-2021 publications reveals dominant themes in pandemic-era rheumatology, featuring eight high-impact studies originating from Hubei province. Her work demonstrates methodological diversity spanning multicenter observational cohorts, molecular pathway analyses, and digital health innovations, with recurring focus on SARS-CoV-2 interactions with autoimmune conditions, NK cell dysregulation in Sjögren's syndrome, and IL-33-mediated psoriasis mechanisms—all contributing to evidence-based clinical guidelines during global health crises. As an academic leader, Dr. Dong mentors graduate researchers while serving the scholarly community through editorial roles including Review Editor for B Cell Biology in Frontiers in Immunology and Rheumatology section editor at Frontiers in Medicine, facilitating critical discourse in immunological and rheumatological research. Within Tongji Hospital's infrastructure, she integrates clinical practice with research innovation through the Department of Rheumatology and Immunology, directing patient-centered investigations that address urgent questions in autoimmune disease management during public health emergencies while advancing fundamental understanding of disease pathogenesis.

Thomas LeonardView profile

Professor

• Lipid signaling
• Protein kinases
• Signal transduction
• +5 more

Thomas Leonard is a tenured Professor at the Max Perutz Labs (University of Vienna), where he leads a research group focused on lipid-mediated signal transduction and structural mechanisms of kinase regulation . His lab combines structural biology , biochemistry , and cell biology to dissect how cells integrate spatial and temporal signals. PhD in Structural Biology (MRC Laboratory of Molecular Biology, Cambridge) Postdoctoral work at NIH, Bethesda His research explores how lipid second messengers like PIP3 and PI3P control kinases such as Akt, PDK1, and Sgk3, with implications for cancer , neurodevelopmental disorders , and metabolic diseases . Recent work redefined PHLPP1/2 as pseudophosphatases and revealed novel activation mechanisms in Protein Kinase D (PKD) and DMPK kinases. The lab's publication trends highlight structural phylogenomics , membrane scaffolding , and allosteric regulation . Collaborations with institutions like LMU Munich and FWF-funded projects underscore their interdisciplinary approach. Lab Manager: Ronja Reinhardt PhD Students: Sumire Antonioli, Magdalena Otto, Lucas Piech, Eva Krotenheerdt, Felix Wolkenstein Master Students: Gabriela Ariza, Emese Galgóczi, Stefan Lenz The lab actively recruits at Master, PhD, and Postdoc levels for molecular signaling research.

Nelly PanteView profile

Professor

• Cell Biology
• Developmental Biology
• Virology
• +5 more

Nelly Pante is a Professor in the Department of Zoology at the University of British Columbia, Faculty of Science. Her research focuses on nucleocytoplasmic transport, particularly the nuclear import of viral genomes and the molecular characterization of nuclear pore complexes (NPCs). Education: Ph.D. from Brandeis University; M.Sc. from The Venezuelan Institute for Scientific Research (IVIC); B.Sc. (Hons.) from Simon Bolivar University Research highlights include: Investigating bidirectional macromolecular transport through NPCs using cellular and molecular techniques, fluorescence, and electron microscopy Studying viral nuclear import of Influenza A, Hepatitis B, baculoviruses, and parvoviruses to develop antiviral strategies Developing the Xenopus oocyte model system for high-resolution nuclear transport studies Structural analysis of nucleoporins like Nup153 and Nup358/RanBP2 in NPC architecture Her lab employs advanced imaging methods and has contributed to understanding how viruses exploit nuclear transport mechanisms and how NPCs maintain cellular function in health and disease. Contact: pante@zoology.ubc.ca

• Signal Regulated Transcription
• Chromatin and Gene Regulation
• Nuclear Receptors
• +7 more

W. Lee Kraus is a Professor and Director at the Cecil H. and Ida Green Center for Reproductive Biology Sciences at UT Southwestern Medical Center, where he also holds leadership roles including Vice Chair for Basic Sciences in the Department of Obstetrics and Gynecology, Assistant Director for Basic Research at the Simmons Comprehensive Cancer Center, and Assistant Dean for Research Development. He is also a member of the Board of Directors of the Endocrine Society (2023–2026). Ph.D., University of Illinois at Urbana-Champaign (1994) Postdoctoral Research, University of California, San Diego B.S., Cornell University (1989) Dr. Kraus's research centers on signal-regulated transcription, chromatin and gene regulation, nuclear receptors, PARPs, and NAD+ metabolism and signaling. His work has elucidated the roles of ADP-ribosylation in transcriptional control, enhancer function, and cancer biology. He has published over 150 peer-reviewed articles in top journals such as Science , Cell , and Molecular Cell . His recent publications reveal a strong focus on PARP enzymes, enhancer RNAs, NAD+ compartmentalization, and the interplay between metabolism and gene regulation. Themes across his work include the functional roles of ADP-ribosylation in transcription, splicing, translation, and cancer, with implications for therapeutic development. Scientific honors include: Endocrine Society’s Richard E. Weitzman Memorial Award (2007) Endocrine Society’s Ernst Oppenheimer Award (2014) Cornell University Teaching Excellence Award (2004) Cornell University Mentoring Excellence Award (2008) Dr. Kraus has been a successful mentor, training 22 doctoral students, 26 postdocs, and 16 clinical fellows, most of whom have secured faculty or research positions in academia or industry. His research has been supported by grants from the NIH, American Cancer Society, Burroughs Wellcome Fund, CPRIT, and NSF. He is also active in biotech, having co-founded Ribon Therapeutics and ARase Therapeutics, and serves on scientific advisory boards for startup companies. He leads the Kraus Lab at UT Southwestern, which continues to pioneer research in transcriptional regulation and metabolic signaling.

Gerta HoxhajView profile

Assistant Professor

• Cancer Metabolism
• Cell Signaling
• Metabolomics
• +5 more

Gerta Hoxhaj is an Assistant Professor at the Children's Medical Center Research Institute (CRI) at UT Southwestern Medical Center, with secondary appointments in the Departments of Biochemistry and Pediatrics. She leads an active research laboratory focused on understanding the molecular mechanisms of cancer metabolism. Dr. Hoxhaj received her academic training through the following institutions: Bachelor's degree in Molecular Biology, Genetics, and Chemistry from Bogazici University, Istanbul, Turkey Ph.D. in Biochemistry and Cell Signaling from the MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Scotland, UK Dr. Hoxhaj's research program centers on understanding how cancer cells rewire their metabolism to support growth and survival. Her laboratory investigates three fundamental questions: how cells integrate oncogenic signals to regulate metabolic activities; how metabolism is linked to tissue function; and how cells sense metabolite abundance to maintain homeostasis. Using approaches that combine classical biochemistry, metabolomics, cell biology, and mouse models, her team has made significant contributions to understanding the role of cellular reducing power (NADPH) in cancer metabolism, particularly through the regulation of NAD kinase (NADK). Her work has revealed novel connections between PI3K-Akt-mTORC1 signaling and metabolic pathways including nucleotide synthesis and redox balance. Analysis of Dr. Hoxhaj's recent publications shows a strong focus on mitochondrial metabolism, particularly the role of NADPH in powering essential processes like fatty acid synthesis and protein lipoylation. Her research bridges structural biology (with cryo-EM studies of NADK), cellular metabolism, and cancer biology, revealing how metabolic reprogramming supports tumor growth. A consistent theme across her work is the identification of how oncogenic signaling pathways directly regulate specific metabolic enzymes and processes. Dr. Hoxhaj has received numerous prestigious awards and recognitions for her research: Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research V Foundation Scholar American Cancer Society Scholar Pew-Stewart Scholar for Biomedical Science 2025 TAMEST Mary Beth Maddox Award and Lectureship 2024 Vilcek Prize for Creative Promise in Biomedical Science Dr. Hoxhaj mentors a dynamic research team including postdoctoral fellows, Ph.D. students, and research associates. Her laboratory has secured significant funding from multiple sources including the National Institutes of Health, Welch Foundation, CPRIT, and USDA National Institute of Food and Agriculture. Her research on cancer metabolism has important implications for developing new therapeutic strategies targeting metabolic vulnerabilities in cancer cells. The Hoxhaj Laboratory is part of the Genetic and Metabolic Disease Program at CRI, collaborating closely with other researchers at UT Southwestern including those in the Harold C. Simmons Comprehensive Cancer Center. Her team's recent work on mitochondrial NADPH has opened new avenues for understanding how metabolic pathways are rewired in cancer, with potential applications for multiple cancer types.

• Neuroscience
• Physiology
• Molecular Biology
• +8 more

Angel Manuel Carrion Rodriguez is a University Professor at the Universidad Pablo de Olavide, affiliated with the Department of Physiology, Anatomy and Cell Biology. His research focuses on Translational Neuroscience and Molecular and Cellular Mechanisms of Neuronal Plasticity. Research Trends: Recent publications highlight roles of HERC1 ubiquitin ligase in autophagy and neurodegenerative diseases, steroid sulfatase inhibitors in Huntington’s and Alzheimer’s therapies, and AMPK–NLRP3 inflammasome interactions in fibromyalgia and pain modulation. Academic Background: He earned his doctorate from Universidad Complutense de Madrid in 1997, supervised by Dr. Jose Ramon Naranjo Orovio. His work intersects Biology, Biotechnology, and Health Sciences. Labs & Groups: He leads the tNeuro Translational Neuroscience Group and has been part of the Neuroscience Laboratory, emphasizing neurodevelopment, synaptic plasticity, and mitochondrial dysfunction.

Adriana B FerreiraView profile

Associate Professor

• Alzheimer's Disease
• Cell Biology
• Cytoskeleton
• +7 more

Adriana B Ferreira, MD, PhD is an Associate Professor in the Department of Cell and Developmental Biology at the Feinberg School of Medicine, Northwestern University. She leads the Adriana Ferreira Lab which focuses on understanding the mechanisms underlying neurite degeneration and synapse loss in neurodegenerative diseases, with particular emphasis on Alzheimer's disease. Dr. Ferreira is also affiliated with the Mesulam Center for Cognitive Neurology and Alzheimer's Disease and the Northwestern University Institute of Neuroscience (NUIN). Dr. Ferreira received her medical degree (MD) from the National University of Cordoba, Argentina in 1981, followed by a PhD in Neuroscience from the same institution in 1985. Her extensive postdoctoral training includes: Neuroscience at the School of Medicine, National University of Cordoba (1985) Neuroscience at the Insitituo de Investigacion Medica (1988) Biology at the University of Virginia (1991) Cell Biology at the Marine Biological Laboratory (1992) Neuroscience at Brigham and Women's Hospital Harvard Medical School (1993) Dr. Ferreira's research primarily investigates the relationship between beta-amyloid deposition and the progressive formation of dystrophic neurites and cell death in hippocampal neurons. Her current work assesses the role of tau in neuronal degeneration mechanisms, using culture and animal models of Alzheimer's disease along with various cell and molecular biology techniques. Her work has significant implications for understanding and potentially treating neurodegenerative disorders characterized by neurite degeneration and synapse loss. Analysis of Dr. Ferreira's recent publications reveals a consistent focus on tau protein fragmentation and its role in neurodegeneration. Her research has evolved from studying basic mechanisms of neurite outgrowth and cytoskeletal organization to investigating specific tau fragments (particularly tau45-230) and their contribution to Alzheimer's disease pathology. More recently, her work has expanded to examine RNA-mediated mechanisms of neurotoxicity, including Death Induced by Survival gene Elimination (DISE) pathways in Alzheimer's disease and aging. Dr. Ferreira has received numerous awards and honors throughout her career: Young Investigator Award, National Alliance for Research in Schizophrenia and Depression (2001) Young Investigator Award, National Alliance for Research in Schizophrenia and Depression (1999) Young Women Investigator, Signa Kappa Foundation (1998) International Fellowship, CONICET (1988) National Fellowship, CONICET (1983) Special Mention (Top of the Class), National University of Cordoba. School of Medicine (1982) Dr. Ferreira serves as a Review Editor for Frontiers in Neuroscience and has been an active member of the Argentinian Research Council (Biology and Medicine Areas) since 1996. She has also contributed to scientific review processes as a reviewer for the Ministry of Health and Consumer's Affairs in Spain (2006-2007). Her long-standing membership in professional societies, including the Society for Neuroscience since 1989, demonstrates her commitment to advancing the field. The Ferreira Lab operates within the Department of Cell and Developmental Biology at Northwestern's Feinberg School of Medicine, with strong connections to the Mesulam Center for Cognitive Neurology and Alzheimer's Disease. The lab employs a range of cellular and molecular approaches to investigate neurodegenerative mechanisms, with particular expertise in neuronal cell culture models and analysis of cytoskeletal changes in neurodegeneration.

Zuri SullivanView profile

Research Fellow

• Immunology
• Neuroscience
• Neuroimmunology
• +5 more

Zuri Sullivan is a postdoctoral researcher at Harvard University, affiliated with the Catherine Dulac Lab. Her work focuses on the intersection of immunology and neuroscience, particularly how inflammatory signals influence social behavior in mice through hypothalamic circuits. Education: PhD in Immunobiology from Yale University AB in Molecular and Cellular Biology (MCB) from Harvard College Research interests span neuroimmunology, inflammation, and genetic screening. Key projects include studying mast cell-leukotriene signaling in anaphylaxis, hypothalamic circuitry in social homeostasis, and the role of γδ T cells in nutrient sensing. Her work often integrates immunobiology with behavioral neuroscience. Recent publications highlight her contributions to understanding immune-gut-brain axis interactions, genetic tools for tissue mapping, and disease mechanisms in obesity-related cancer and tuberculosis. She also develops innovative multimodal screening platforms for in vivo gene function analysis. Scientific Awards: HHMI Hanna H. Gray Postdoctoral Fellowship Zuri actively promotes science communication, diversity in STEM, and education outreach. She previously studied intestinal immune adaptation to diet during her PhD at Yale under Ruslan Medzhitov. Collaborations with William Bishai and Ruslan Medzhitov feature prominently in her research portfolio.

Michael LandsbergView profile

Associate Professor

• Structural Biology
• Cryo-Electron Microscopy
• Microbial Pathogenesis
• +6 more

Dr. Michael Landsberg is an Affiliate Associate Professor at the Institute for Molecular Bioscience and Associate Professor at the School of Chemistry and Molecular Biosciences , University of Queensland . He specializes in single-particle cryo-electron microscopy (cryo-EM) and structural biology , focusing on molecular machines involved in microbial pathogenesis and innate immunity . His research spans from studying bacterial pore-forming toxins to viral infection mechanisms and protein trafficking . Education: BSc (Chemistry), Central Queensland University PhD (Biochemistry), University of Queensland (2003) Research interests include revolutionizing structural biology through cryo-EM to study membrane proteins and multi-component complexes without crystallization. His work on ABC toxins has implications for biopesticides and targeted protein delivery . He also investigates immune signaling pathways (e.g., TIR domains ) and neurodegenerative mechanisms (e.g., SARM1 ). Scientific grants include >$13.5M in competitive funding from Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC) . He supervises PhD students in projects spanning toxin specificity , immune signaling , and virus structures . Key article trends reveal expertise in macromolecular complexes , infectious disease mechanisms , and innovative biotechnological tools . His work bridges structural biology with practical applications in health and agriculture .

• Plant Pathology
• Grapevine Diseases
• Molecular Plant-Microbe Interactions
• +3 more

Julie Chong is a Full Professor at the University of Haute-Alsace (UHA) in Colmar, France, affiliated with the Faculty of Marketing and Agrosciences. She directs the Laboratory of Vine, Biotechnologies and Environment (LVBE) and holds key administrative roles including leadership of the Master 1 'Valorization and Transformation of Agricultural Products' program and the Agronomy pole at UHA. Her academic qualifications include a Habilitation to Supervise Research (2012) from UHA on induced plant defenses in grapevine resistance to cryptogamic diseases, and a PhD in Cellular and Molecular Biology (2001) from the CNRS Institute of Molecular Plant Biology in Strasbourg, where her doctoral research focused on salicylic acid biosynthesis and pathogen-induced glucosyltransferases. Professor Chong's research program investigates molecular mechanisms of grapevine defense against trunk diseases, particularly Botryosphaeria dieback. Her laboratory characterizes defense signaling pathways (notably VvNPR1), studies the role of sugar transporters (SWEET family) in pathogen interactions, and explores resistance sources in wild grapevine species ( Vitis vinifera subsp. sylvestris ). She employs advanced techniques in molecular biology, metabolomics, and pathogen characterization to dissect host-pathogen dynamics and identify sustainable disease control strategies, with emphasis on fungal virulence factors and plant immune responses. Analysis of her 15 most recent publications (2016-2025) reveals consistent focus on effector-triggered immunity, metabolic reprogramming during infection, and biotechnological enhancement of grapevine resilience. Key themes include characterization of fungal secreted proteins, symbiotic interactions with mycorrhizal fungi, and engineering of disease resistance through transporter overexpression, demonstrating translational applications for viticulture. Her scientific contributions have been recognized with: Prime d'Excellence Scientifique (2014) from University of Haute-Alsace Innovative Project Grants from University of Haute-Alsace Professor Chong actively supervises Master's students in the 'Sciences and Technologies of Agriculture, Food and Environment' program, guiding internships and R&D projects. She serves on doctoral committees (EDSC222) and contributes to academic governance as an elected faculty council member. Her research is supported by institutional grants for innovative projects and collaborative initiatives with the regional wine industry. As Director of LVBE, she leads a multidisciplinary team investigating viticultural challenges, maintaining strong connections with the University of Strasbourg doctoral school and Alsace winegrowers to address trunk disease epidemics through integrated molecular and ecological approaches.

Paul KingsleyView profile

Academic

• Embryonic Hematopoiesis
• Erythroid Differentiation
• Ontogeny of Hematopoietic Progenitors
• +3 more

Paul Kingsley, Ph.D. is a Research Assistant Professor (Part-Time) in the Department of Pediatrics, Hematology and Oncology at the University of Rochester School of Medicine and Dentistry. His academic credentials include a Ph.D. and M.S. in Developmental Biology from the University of Rochester (1992, 1987) and a B.A. in Biology from Reed College (1982), followed by a Cancer Center Fellowship in Hematopoiesis at the University of Rochester School of Medicine and Dentistry (1992-1994). Dr. Kingsley's research focuses on: Embryonic Hematopoiesis Erythroid Differentiation Ontogeny of Hematopoietic Progenitors Erythroid Precursor Self Renewal His laboratory employs diverse approaches including subtractive hybridization, degenerate PCR, genechip technology (Affymetrix), and in situ hybridization to investigate blood formation in mammalian embryos. His work examines how hematopoiesis initiates in the yolk sac, migrates to the fetal liver, and finally homes to the bone marrow at the end of gestation. Dr. Kingsley's publication record demonstrates consistent focus on molecular mechanisms of blood cell development, with recent work emphasizing erythroid maturation, hematopoietic stem cell regulation, and chromatin dynamics during erythropoiesis. His research spans from fundamental developmental biology to potential clinical applications in blood disorders and radiation protection. Key research contributions include: Mechanisms of erythroblast enucleation and maturation Regulation of hematopoietic stem cell specification and migration Chromatin remodeling during late-stage erythropoiesis Mitochondrial iron metabolism in heme synthesis Developmental origins of immune cell lineages Effects of radiation on hematopoietic recovery Dr. Kingsley has maintained a productive research career with extensive collaboration, particularly with Dr. James Palis, resulting in numerous high-impact publications in journals such as Nature, Science, Blood, and The EMBO Journal.

• Hematopoiesis
• Developmental Biology
• Imaging Flow Cytometry
• +3 more

Kathleen E. McGrath is a Research Professor in the Department of Pediatrics, Hematology and Oncology at the University of Rochester School of Medicine and Dentistry. She earned her Ph.D. in Biology from the University of Rochester in 1993, an M.S. in Biology from the same institution in 1987, and a B.A. in Biology from Reed College in 1983. Dr. McGrath's research focuses on the emergence and regulation of hematopoiesis in mammalian embryos and its recovery post-radiation. She specializes in imaging flow cytometry for analyzing rare hematopoietic populations and studies erythroid-myeloid progenitors during embryogenesis. Her work intersects developmental biology, hematology, and regenerative medicine. Her recent publications highlight advancements in erythroid self-renewal, megakaryocyte immune roles, and radiation injury recovery. Notable collaborations include contributions to the Palis Lab's investigations into hematopoietic stem cell dynamics and niche interactions. Scientific Awards: Leon Wheeless Innovation in Cytometry Award (2007)

• Progranulin research
• Neuroprotection
• Tissue repair
• +4 more

Andrew Bateman, PhD is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, where he leads research in the Metabolic Disorders and Complications Program within the Centre for Translational Biology. He holds a professorship in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University, with specific affiliation to the Division of Endocrinology at the McGill University Health Centre. Dr. Bateman's research primarily focuses on progranulin, a protein that plays crucial roles in cell communication, neuroprotection, tissue repair, and cancer progression. His work has demonstrated that progranulin instructs nearby cells to divide and move, inhibits cell death caused by challenges such as starvation or chemotherapeutic drugs, and is essential for keeping nerve cells alive. Notably, his research has shown that losing half of the brain's progranulin levels through mutation causes frontotemporal dementia, a devastating degenerative brain disease. His laboratory also investigates how progranulin is overexpressed in many cancers, rendering cancer cells more aggressive, and how blocking progranulin may serve as a route to cancer therapy. Additionally, his work explores progranulin's role in reducing inflammation and promoting wound repair, including angiogenesis, which has potential applications for people suffering from chronic wounds. Analysis of Dr. Bateman's publication record reveals a consistent focus on progranulin across multiple disciplines including neuroscience, molecular biology, oncology, and vascular biology. His research spans from fundamental protein structure and evolution to clinical applications in neurodegenerative diseases and cancer. A notable trend in his work is the exploration of progranulin's dual role in both neuroprotection and cancer progression, highlighting the complex nature of this regulatory protein. His research has evolved from early work on corticostatic peptides and the immune-hypothalamic-pituitary-adrenal axis to his current specialized focus on progranulin's multifaceted biological functions. Dr. Bateman has made significant contributions to understanding the role of progranulin in various physiological and pathological processes. His work has implications for developing therapeutic approaches for neurodegenerative diseases, cancer treatment, and wound healing. He has established himself as a leading researcher in the field of progranulin biology, with numerous publications in high-impact journals spanning several decades of research.

Elizabeth FixmanView profile

Associate Professor

• Immunology
• Respiratory Diseases
• Type 2 Inflammation
• +4 more

Elizabeth Fixman is an Associate Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), Glen site. She leads the Translational Research in Respiratory Diseases Program at the Centre for Translational Biology, conducting research at the Meakins-Christie Laboratories. Education BSc in Chemistry/Biochemistry from Colorado State University (1986) PhD in Pharmacology from Johns Hopkins University (1992) Research Focus Dr. Fixman's research employs murine models to investigate innate and adaptive immune coordination in type 2 inflammation within allergic airways disease. Key areas include: IL-33 and RSV activation of lung innate cells, STAT6 pathways in eosinophils, immunomodulatory peptide development (STAT6-IP), and sex hormone influences on inflammatory responses. Her work bridges immunology, respiratory pathophysiology, and therapeutic innovation. Publication Trends Her recent publications (2013-2024) demonstrate consistent focus on STAT6 signaling pathways, sex-based differences in immune responses, dendritic cell migration mechanisms, and novel peptide therapeutics. Research utilizes murine models to explore neonatal immunity, viral reinfection outcomes, and cellular metabolism in immune regulation, with translational applications for asthma and allergic diseases. Teaching and Laboratory She teaches 'Advanced Topics in Respiration' (EXMD 508) and leads a laboratory at the RI-MUHC Glen site investigating immunological mechanisms in respiratory diseases.